biotect-valuation
The premium Open Source alternative to Evaluate Pharma
🎯 Best for:Financial analysts requiring transparent biotech valuation methodologies
What is biotect-valuation?
Replaces manual biotech financial modeling with an AI-driven 4-factor framework. Automates risk-adjusted NPV calculations using clinical trial success probabilities and market data.
Tech Stack
PythonFinance & Accounting
Why biotect-valuation?
- • Automated rNPV calculation
- • AI-driven risk assessment
- • Transparent valuation logic
Limitations
- • Requires financial domain knowledge
- • API costs for LLM usage
- • Limited historical data
12/14/2025
Last Update
0
Forks
0
Issues
Unknown
License
Financial Leak Detected
Stop the "SaaS Tax"
Your team could be burning cash. Switching to biotect-valuation instantly boosts your runway.
Competitor Cost
-$1,440
/ year (est. based on Evaluate Pharma)
Self-Hosted
$0
/ year
Team Size10 Users
150+
SAVE 100%